Status and phase
Conditions
Treatments
About
The purpose of this study is to determine the effectiveness & safety of pirfenidone in type 2 diabetic patients with diabetic nephropathy
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
AP Endocrinology
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal